Stock listing
NASDAQ:IART Integra LifeSciences Holdings Corporation Stock
Home listing (NASDAQ) of Integra LifeSciences Holdings Corporation
Follow Integra LifeSciences Holdings Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:IART
$13.25 USD -0.61 (-4.4%)
Close on Nov 20, 2026
- Day range
- $13.16 – $13.79 USDNov 20, 2026
- Volume
- 826,614 sharesNov 20, 2026
- Market cap
- $1.03B USDAt the close on Nov 20, 2026 · price × 77.80M shares outstanding
- 52-week range
- $8.70 – $20.49 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $14.79M USDMedian day 998,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IART · Home | $13.25 USD | -0.61 (-4.4%) | 826,614 | $13.38 | $13.79 | $13.16 | $13.86 | Close on Nov 20, 2026 |
| Munich:IL3 | €12.40 EUR | -0.20 (-1.6%) | — | €12.40 | €12.40 | €12.40 | €12.60 | Close on Nov 20, 2026 |
| Frankfurt:IL3 | €12.10 EUR | -0.20 (-1.6%) | — | €12.10 | €12.10 | €12.10 | €12.30 | Close on Nov 20, 2026 |
| Stuttgart:IL3 | €12.50 EUR | +0.20 (+1.6%) | — | €13.00 | €13.30 | €12.20 | €12.30 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:IART · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $13.25 | -0.61 | -4.4% | $13.38 | $13.79 | $13.16 | 826,614 | |
| $13.86 | +0.31 | +2.3% | $13.40 | $13.94 | $13.40 | 575,006 | |
| $13.55 | -0.43 | -3.1% | $13.82 | $13.88 | $13.40 | 1,169,745 | |
| $13.98 | -0.42 | -2.9% | $14.30 | $14.52 | $13.94 | 706,376 | |
| $14.40 | +0.05 | +0.3% | $14.42 | $14.58 | $14.15 | 648,836 | |
| $14.35 | -0.42 | -2.8% | $14.62 | $14.93 | $14.13 | 1,071,197 | |
| $14.77 | +0.24 | +1.7% | $14.55 | $15.07 | $14.39 | 1,000,165 | |
| $14.53 | +0.16 | +1.1% | $14.37 | $14.76 | $13.78 | 1,770,753 | |
| $14.37 | +0.95 | +7.1% | $13.66 | $14.40 | $13.42 | 1,035,800 | |
| $13.42 | -0.70 | -5.0% | $13.94 | $14.13 | $13.32 | 871,884 | |
| $14.12 | -0.70 | -4.7% | $14.87 | $15.25 | $13.73 | 992,058 | |
| $14.82 | +1.19 | +8.7% | $13.97 | $15.15 | $13.84 | 1,174,233 | |
| $13.63 | +0.02 | +0.1% | $13.69 | $13.74 | $13.43 | 1,693,410 | |
| $13.61 | +0.86 | +6.7% | $12.98 | $13.97 | $12.98 | 1,504,288 | |
| $12.75 | -0.08 | -0.6% | $12.74 | $12.85 | $12.34 | 1,038,769 | |
| $12.83 | +0.59 | +4.8% | $12.43 | $13.01 | $12.28 | 1,188,112 | |
| $12.24 | +0.25 | +2.1% | $11.98 | $12.33 | $11.93 | 1,789,006 | |
| $11.99 | -0.11 | -0.9% | $12.25 | $12.25 | $11.72 | 1,431,835 | |
| $12.10 | +0.19 | +1.6% | $12.05 | $12.24 | $12.00 | 916,421 | |
| $11.91 | -0.415 | -3.4% | $12.12 | $12.40 | $11.82 | 1,212,688 | |
| $12.33 | +0.485 | +4.1% | $11.69 | $12.36 | $11.66 | 1,386,962 | |
| $11.84 | -1.49 | -11.2% | $12.77 | $13.75 | $11.57 | 2,017,659 | |
| $13.33 | -0.12 | -0.9% | $13.51 | $13.76 | $13.27 | 1,308,014 | |
| $13.45 | +0.24 | +1.8% | $13.13 | $13.49 | $13.11 | 726,141 | |
| $13.21 | -0.32 | -2.4% | $13.65 | $13.83 | $13.10 | 831,000 | |
| $13.53 | +0.35 | +2.7% | $13.38 | $13.64 | $13.29 | 1,334,200 | |
| $13.18 | -0.67 | -4.8% | $13.45 | $13.79 | $12.92 | 1,105,400 | |
| $13.85 | -0.13 | -0.9% | $14.05 | $14.28 | $13.66 | 818,800 | |
| $13.98 | +0.54 | +4.0% | $13.43 | $14.03 | $13.42 | 893,700 | |
| $13.44 | +0.03 | +0.2% | $13.38 | $13.86 | $13.23 | 1,228,100 | |
| $13.41 | +0.41 | +3.2% | $12.86 | $13.44 | $12.83 | 1,459,600 | |
| $13.00 | -0.32 | -2.4% | $13.19 | $13.46 | $12.98 | 1,408,500 | |
| $13.32 | +0.03 | +0.2% | $13.46 | $13.51 | $12.88 | 1,369,200 | |
| $13.29 | +0.61 | +4.8% | $12.65 | $13.49 | $12.35 | 1,859,000 | |
| $12.68 | -3.41 | -21.2% | $13.31 | $14.00 | $12.63 | 2,693,900 | |
| $16.09 | -0.19 | -1.2% | $16.21 | $16.45 | $15.88 | 652,900 | |
| $16.28 | -0.36 | -2.2% | $16.67 | $16.67 | $16.14 | 768,900 | |
| $16.64 | +0.37 | +2.3% | $16.27 | $16.77 | $15.80 | 1,005,200 | |
| $16.27 | +0.15 | +0.9% | $16.04 | $16.27 | $15.86 | 479,000 | |
| $16.12 | +0.24 | +1.5% | $15.88 | $16.21 | $15.74 | 539,000 | |
| $15.88 | +0.35 | +2.3% | $15.67 | $15.91 | $15.49 | 759,500 | |
| $15.53 | -0.49 | -3.1% | $15.88 | $16.26 | $15.38 | 573,100 | |
| $16.02 | +0.43 | +2.8% | $15.90 | $16.29 | $15.69 | 770,500 | |
| $15.59 | +0.37 | +2.4% | $15.06 | $15.65 | $14.91 | 1,064,200 | |
| $15.22 | +0.12 | +0.8% | $14.98 | $15.24 | $14.88 | 2,169,100 | |
| $15.10 | -0.96 | -6.0% | $16.30 | $16.38 | $15.07 | 1,051,300 | |
| $16.06 | +0.37 | +2.4% | $15.81 | $16.22 | $15.65 | 1,618,100 | |
| $15.69 | -0.02 | -0.1% | $15.69 | $16.04 | $15.20 | 1,077,600 | |
| $15.71 | +0.21 | +1.4% | $15.36 | $15.80 | $15.36 | 1,141,800 | |
| $15.50 | -0.04 | -0.3% | $16.06 | $16.22 | $15.33 | 792,000 | |
| $15.54 | -0.71 | -4.4% | $15.93 | $16.04 | $15.39 | 1,362,000 | |
| $16.25 | -0.01 | -0.1% | $16.10 | $16.46 | $15.99 | 578,400 | |
| $16.26 | -0.46 | -2.8% | $16.48 | $16.55 | $15.99 | 621,800 | |
| $16.72 | +0.28 | +1.7% | $16.32 | $16.78 | $16.25 | 674,300 | |
| $16.44 | -0.37 | -2.2% | $17.09 | $17.11 | $16.28 | 998,500 | |
| $16.81 | +0.19 | +1.1% | $16.80 | $17.21 | $16.66 | 528,900 | |
| $16.62 | -0.30 | -1.8% | $16.84 | $17.08 | $16.54 | 559,700 | |
| $16.92 | +0.03 | +0.2% | $16.81 | $16.95 | $16.48 | 581,100 | |
| $16.89 | +0.04 | +0.2% | $16.97 | $17.33 | $16.87 | 776,200 | |
| $16.85 | -0.03 | -0.2% | $16.85 | $17.17 | $16.79 | 449,800 | |
| $16.88 | +0.09 | +0.5% | $16.85 | $17.10 | $16.62 | 489,400 | |
| $16.79 | +0.10 | +0.6% | $16.73 | $16.87 | $16.39 | 369,500 | |
| $16.69 | -0.05 | -0.3% | $16.74 | $17.00 | $16.39 | 654,700 | |
| $16.74 | +0.15 | +0.9% | $16.81 | $16.94 | $16.44 | 551,000 | |
| $16.59 | -0.65 | -3.8% | $17.01 | $17.47 | $16.56 | 582,300 |
Splits
2 splits since 1998 · NASDAQ:IART · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 1-for-2 | Consolidation |
- Ticker
- NASDAQ:IART
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
Latest earnings call · Oct 2, 2026
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 21, 2026
Q3 2026 Earnings Presentation
Earnings · 19 slides
Latest news
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
Nov 6, 2026
Closed $13.42 (-5.0%) on Nov 6, 2026
Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
Oct 30, 2026
Closed $12.75 (-0.6%) on Oct 30, 2026
Integra LifeSciences Reports Third Quarter 2026 Financial Results
Oct 21, 2026
Closed $11.84 (-11.2%) on Oct 21, 2026
Integra Announces Completion of Refinancing Transactions
Oct 19, 2026
Closed $13.33 (-0.9%) on Oct 20, 2026
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
Oct 16, 2026
Closed $13.21 (-2.4%) on Oct 16, 2026
Integra Announces Pricing of Senior Secured Notes
Oct 9, 2026
Closed $13.98 (+4.0%) on Oct 12, 2026
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
Oct 6, 2026
Closed $13.32 (+0.2%) on Oct 6, 2026
Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance
Oct 5, 2026
Closed $13.29 (+4.8%) on Oct 5, 2026
Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
Oct 2, 2026
Closed $12.68 (-21.2%) on Oct 2, 2026
Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry
Sep 29, 2026
Closed $16.64 (+2.3%) on Sep 29, 2026
Integra LifeSciences Holdings Corporation on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 33 in the last 12 months · 148 in all · newest Nov 6, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Oct 2, 2026
- Decks
- 40 decks · latest Oct 21, 2026
Where Integra LifeSciences Holdings Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IART · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:897013 | LS Exchange | Germany | EUR |
| Lang & Schwarz:897013 | Lang & Schwarz | Germany | EUR |
| gettex:IL3 | gettex | Germany | EUR |
| BOATS:IART | BOATS | United States | USD |
| Munich:IL3 | Munich | Germany | EUR |
| BX Swiss:IL3 | BX Swiss | Switzerland | CHF |
| Dusseldorf:IL3 | Dusseldorf | Germany | EUR |
| Frankfurt:IL3 | Frankfurt | Germany | EUR |
| Stuttgart:IL3 | Stuttgart | Germany | EUR |
| Tradegate:IL3 | Tradegate | Germany | EUR |
Valuation
P/E 79.2× against a median of 22.8×: 6th lowest of 7 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.42B USD
- P/E
- 79.2×
- EV/sales
- 0.8×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.0×
- Gross margin
- 52.4%
- Operating margin
- 4.4%
- Net margin
- 0.8%
- Debt to equity
- 0.7×
- Beta vs S&P 500
- 1.47
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corporation · NASDAQ:IART | US$1.03B | US$1.42B | 79.2× | 0.8× | n/a | 1.0× | 0.8% | 0.7× | 1.47 |
| Shandong Weigao Orthopaedic Device Co., Ltd. Class A · SSE:688161 | US$1.09B | US$897.1M | 30.3× | 4.3× | n/a | 1.7× | 17.2% | 0.0× | n/a |
| SI-BONE, Inc. · NASDAQ:SIBN | US$1.07B | US$1.07B | n/a | 4.8× | n/a | 5.8× | −6.2% | 0.2× | 0.62 |
| CeriBell, Inc. · NASDAQ:CBLL | US$1.06B | US$967.9M | n/a | 8.9× | n/a | 9.1× | −68.0% | 0.2× | 0.82 |
| CLASSYS Inc. · KRX:214150 | US$1.06B | US$959.6M | 10.3× | 3.5× | 7.0× | 2.6× | 37.3% | 0.0× | n/a |
| Shinva Medical Instrument Co. Ltd. Class A · SSE:600587 | US$1.04B | US$608.1M | 15.3× | 0.4× | n/a | 0.9× | 4.5% | 0.0× | n/a |
| Alphatec Holdings, Inc. · NASDAQ:ATEC | US$1.04B | US$1.51B | n/a | 1.8× | 31.6× | n/a | −10.3% | n/a | 1.26 |
| iRadimed Corporation · NASDAQ:IRMD | US$1.04B | US$972.8M | 43.2× | 10.9× | 31.9× | 9.7× | 26.9% | 0.0× | 0.65 |
| Draegerwerk AG & Co. KGaA · XETR:DRW8 | US$986.0M | US$911.4M | 5.3× | 0.2× | 2.0× | 0.5× | 4.7% | 0.1× | n/a |
| Shenzhen Edge Medical Co., Ltd. Class H · HKEX:2675 | US$973.1M | US$695.5M | n/a | 10.2× | n/a | 2.8× | −19.4% | 0.0× | n/a |
| Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A · SZSE:301234 | US$952.4M | US$890.2M | 354× | 14.4× | n/a | 8.3× | 4.3% | 0.0× | n/a |
| Median of the others | US$1.04B | US$935.5M | 22.8× | 4.6× | 19.3× | 2.8× | 4.4% | 0.0× | 0.74 |
Forecasts
2 strong buy · 1 buy · 7 hold · 2 sell · Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 15.67 USD · Analysts' mean
- EPS, year to Dec 2026
- 2.34 · 12 analysts
- Revenue, year to Dec 2026
- 1.64B · 11 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Stuart Essig | president and chief executive officer, Chairman |
| Lea Daniels Knight | Executive Vice President and Chief Financial Officer |
| Christopher Kilburn-Peterson | Corporate Vice President and President, Tissue Reconstruction |
| Harvinder Singh | Executive Vice President and President, Specialty Surgery |
| Jeff Graves | President, 3D Systems Corporation |
| Robert T. Davis | Executive Vice President and President, Tissue Reconstruction and Distributed Technologies |
| Lesha Shinn | Corporate Vice President, Chief Legal Officer and Company Secretary |
| Chris Ward | Investor Relations |
| Andrea Caruso | Corporate Vice President and Chief Human Resources Officer |
| Dimitri Kvares | Corporate Vice President and Chief Information Officer |
| Kerri DiPietro | Corporate Vice President and Chief Quality Officer |
| Michael McBreen | Executive Vice President and Chief Commercial Officer |
| Raymond Turner | Corporate Vice President and Chief Medical Officer |
| Rick Maveus | Senior Vice President, Transformation and Program Management Office |
| Teshtar Elavia | Corporate Vice President and Chief Technology Officer |
| Topaz Joy Kirlew | Corporate Vice President and Chief Regulatory Officer |
| Valerie Young | Corporate Vice President, Global Supply Chain |
| Renee Lo | Vice President APAC, Sales Solutions for LinkedIn Corporation; Chair of the Compensation Committee |
Board
| Director | Role |
|---|---|
| Stuart Essig | president and chief executive officer, Chairman |
Events
Calls
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 21, 2026 · Before open | −11.2% |
| Q2 2026 | Jul 29, 2026 · Before open | −16.6% |
| Q1 2026 | May 5, 2026 · Before open | +24.1% |
| Q4 2025 | Feb 26, 2026 | −1.8% |
| Q3 2025 | Oct 30, 2025 · Before open | −23.5% |
| Q2 2025 | Jul 31, 2025 · Before open | +6.2% |
| Q1 2025 | May 5, 2025 · Before open | −21.2% |
| Q4 2024 | Feb 26, 2025 · Before open | −4.5% |
| Q3 2024 | Nov 4, 2024 · Before open | +25.1% |
| Q2 2024 | Jul 29, 2024 · Before open | −19.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 6, 2024 · Before open | −19.9% |
| Q4 2023 | Feb 28, 2024 · Before open | −12.7% |
| Q3 2023 | Oct 25, 2023 · Before open | −5.0% |
| Q2 2023 | Jul 26, 2023 · After close | −2.2% |
| Q1 2023 | Apr 26, 2023 · Before open | −7.9% |
| Q4 2022 | Feb 22, 2023 · Before open | −1.2% |
| Q3 2022 | Oct 26, 2022 · Before open | +5.8% |
| Q2 2022 | Jul 27, 2022 · Before open | −1.1% |
| Q1 2022 | Apr 27, 2022 · Before open | +2.4% |
| Q4 2021 | Feb 23, 2022 · Before open | −1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 19 slides | Oct 21, 2026 |
| Investor Presentation (September 2026) | Investor deck | 54 slides | Sep 8, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 19 slides | Jul 29, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 19 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 22 slides | Feb 26, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 14 slides | January 2026 |
| Q3 2025 Earnings Presentation | Earnings | 19 slides | Oct 30, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 19 slides | Jul 31, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 19 slides | May 5, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 21 slides | Feb 25, 2025 |
All 40 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2024 Earnings Presentation | Earnings | 21 slides | Nov 4, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 19 slides | Jul 29, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 19 slides | May 6, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 21 slides | Feb 28, 2024 |
| 2024 JP Morgan Healthcare Conference | Conference | 17 slides | January 2024 |
| Merger or Acquisition (December 2023) | Merger or acquisition | 12 slides | Dec 13, 2023 |
| Q3 2023 Earnings Presentation | Earnings | 21 slides | Oct 25, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 22 slides | Jul 27, 2023 |
| Investor Day (May 2023) | Investor day | 94 slides | May 4, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 20 slides | Apr 26, 2023 |
| FY2022 Earnings Presentation | Earnings | 24 slides | Feb 22, 2023 |
| 2023 JP Morgan Healthcare Conference | Conference | 20 slides | Jan 10, 2023 |
| Merger or Acquisition (December 2022) | Merger or acquisition | 10 slides | Dec 1, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 19 slides | Apr 27, 2022 |
| FY2021 Earnings Presentation | Earnings | 26 slides | Feb 23, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 22 slides | Nov 2, 2021 |
| Q1 2017 Earnings Presentation | Earnings | 18 slides | Apr 26, 2017 |
| Q4 2016 Earnings Presentation | Earnings | 22 slides | Feb 23, 2017 |
| Merger or Acquisition (February 2017) | Merger or acquisition | 26 slides | Feb 15, 2017 |
| Merger or Acquisition (January 2017) | Merger or acquisition | 7 slides | Jan 11, 2017 |
| Q3 2017 Earnings Presentation | Earnings | 20 slides | 2017 |
| Q2 2016 Earnings Presentation | Earnings | 21 slides | Jul 28, 2016 |
| Q2 2015 Earnings Presentation | Earnings | 23 slides | Jul 30, 2015 |
| Jefferies' 2015 Global Healthcare Conference | Conference | 23 slides | June 2015 |
| Corporate Update (April 2015) | Corporate update | 7 slides | Apr 13, 2015 |
| Investor Presentation (2015) | Investor deck | 35 slides | 2015 |
| Investor Presentation (November 2014) | Investor deck | 23 slides | Nov 13, 2014 |
| Q1 2009 Earnings Presentation | Earnings | 15 slides | May 6, 2009 |
| Investor Presentation | Investor deck | 24 slides | |
| Investor Presentation | Investor deck | 33 slides |
Financings
| Raise | Date |
|---|---|
| 9.500% senior secured notes due 2033 Closed: US$450M raised Use of proceeds: With credit facility borrowings, to refinance its existing credit facility and pay related fees and expenses | Oct 19, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.64B | 1.61B | 1.54B | 1.56B | 1.54B | 1.37B | 1.52B | 1.47B | 1.19B | 992.1M |
| Cost of revenue | 803.6M | 728.5M | 656.8M | 587.4M | 597.8M | 520.8M | 564.7M | 571.5M | 435.5M | 349.1M |
| Gross profit | 831.6M | 882.1M | 884.7M | 970.3M | 944.6M | 851.0M | 952.9M | 900.9M | 752.7M | 643.0M |
| Research and development | 99.0M | 115.4M | 104.2M | 101.2M | 93.1M | 77.4M | 79.6M | 78.0M | 63.5M | 58.2M |
| Selling, general and administrative | 699.7M | 717.0M | 656.6M | 616.3M | 637.4M | 594.5M | 687.6M | 690.7M | 624.1M | 455.6M |
| Operating income | -493.4M | 28.4M | 111.5M | 238.9M | 197.2M | 151.4M | 93.8M | 111.0M | 44.8M | 115.3M |
| Depreciation and amortization | 44.8M | 42.4M | 40.9M | 40.1M | 39.4M | 42.1M | 109.5M | 110.7M | 88.9M | 72.7M |
| EBITDA | -448.6M | 70.8M | 152.4M | 279.0M | 236.6M | 193.5M | 203.2M | 221.7M | 133.7M | 188.0M |
| Interest expense | 86.3M | 70.6M | 51.4M | 49.6M | 50.4M | 71.6M | 54.0M | 64.7M | 35.0M | 25.8M |
| Income before tax | -563.5M | -18.2M | 81.1M | 213.9M | 214.7M | 93.5M | 60.1M | 57.4M | 11.4M | 90.4M |
| Income tax | -47.0M | -11.3M | 13.3M | 33.3M | 45.6M | -40.4M | 9.90M | -3.40M | -53.4M | 15.8M |
| Net income | -516.5M | -6.94M | 67.7M | 180.6M | 169.1M | 133.9M | 50.2M | 60.8M | 64.7M | 74.6M |
| Earnings per share, basic | -6.74 | -0.09 | 0.85 | 2.18 | 2.00 | 1.58 | 0.59 | 0.73 | 0.84 | 1.00 |
| Earnings per share, diluted | -6.74 | -0.09 | 0.84 | 2.16 | 1.98 | 1.57 | 0.58 | 0.72 | 0.82 | 0.94 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 235.0M | 246.4M | 276.4M | 456.7M | 513.4M | 470.2M | 198.9M | 138.8M | 174.9M | 102.1M |
| Short-term investments | 28.7M | 27.2M | 32.7M | 0 | 0 | |||||
| Receivables | 278.8M | 272.4M | 259.3M | 263.5M | 231.8M | 225.5M | 275.3M | 265.7M | 251.8M | 148.2M |
| Inventory | 492.7M | 429.1M | 389.6M | 324.6M | 317.4M | 310.1M | 316.1M | 280.3M | 296.3M | 217.3M |
| Current assets | 1.16B | 1.08B | 1.06B | 1.16B | 1.15B | 1.24B | 858.2M | 775.1M | 822.1M | 495.2M |
| Property, plant and equipment | 444.3M | 405.7M | 340.2M | 311.3M | 311.7M | 287.5M | 337.4M | 300.1M | 269.3M | 222.4M |
| Goodwill | 615.2M | 1.10B | 1.06B | 1.04B | 1.01B | 932.4M | 954.3M | 926.5M | 937.9M | 510.6M |
| Total assets | 3.60B | 4.04B | 3.78B | 3.89B | 3.78B | 3.62B | 3.30B | 3.11B | 3.21B | 1.81B |
| Current liabilities | 456.0M | 922.1M | 307.0M | 320.9M | 340.0M | 401.0M | 331.3M | 262.6M | 348.9M | 123.6M |
| Total debt | 726.6M | 760.5M | 775.0M | 775.0M | 843.8M | 877.5M | 877.5M | 900.0M | ||
| Total liabilities | 2.56B | 2.49B | 2.19B | 2.09B | 2.10B | 2.10B | 1.89B | 1.73B | 2.25B | 968.3M |
| Shareholders' equity | 1.04B | 1.55B | 1.59B | 1.80B | 1.68B | 1.51B | 1.42B | 1.38B | 962.3M | 839.7M |
| Shares outstanding | 77.8M | 77.8M | 77.9M | 77.9M | 77.2M | 78.2M | 81.6M | 83.2M | 84.4M | 84.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 50.4M | 129.4M | 140.0M | 264.5M | 312.4M | 203.8M | 231.4M | 199.7M | 114.5M | 116.4M |
| Capital spending | -81.4M | -104.4M | -66.9M | -42.3M | -48.0M | -38.9M | -69.5M | -77.7M | -43.5M | -47.3M |
| Free cash flow | -31.1M | 25.0M | 73.1M | 222.1M | 264.4M | 164.9M | 161.9M | 121.9M | 71.0M | 69.1M |
| Cash from investing | -108.1M | -390.8M | -94.2M | -58.6M | -161.4M | -68.1M | -162.7M | -49.7M | -1.22B | -42.6M |
| Cash from financing | 28.3M | 237.9M | -229.9M | -252.0M | -98.2M | 121.6M | -8.77M | -180.9M | 1.17B | -15.1M |
| Share buybacks | -221.0K | -52.5M | -275.0M | -125.0M | 0 | -100.0M | 0 | 0 | ||
| Change in cash | -11.3M | -30.0M | -180.3M | -56.8M | 43.3M | 271.3M | 60.1M | -36.1M | 72.9M | 53.9M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Oct 23, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 21, 2026 | Results | SEC |
| 8-K · Current report | Oct 19, 2026 | Material contract | SEC |
| 3 · Initial statement of ownership | Oct 13, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 9, 2026 | Current report | SEC |
| 8-K · Current report | Oct 2, 2026 | Results | SEC |
| 3 · Initial statement of ownership | Sep 28, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 8, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 4, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 31, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jul 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| SCHEDULE 13G · Big-stake notice | May 15, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 8, 2026 | Offer document | SEC |
| 8-K · Current report | May 8, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | May 5, 2026 | Meeting notice | SEC |
| 8-K · Current report | May 5, 2026 | Management or board change | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| 8-K · Current report | Apr 15, 2026 | Material contract | SEC |
| DEF 14A · Proxy statement | Apr 6, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| S-3ASR · Registration statement | Feb 26, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 12, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 6, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 6, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 5, 2025 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jul 31, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Jul 31, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 17, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 9, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 9, 2025 | Material contract | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| SCHEDULE 13G · Big-stake notice | May 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 13, 2025 | Management or board change | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | May 9, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2025 | Results | SEC |
| DEF 14A · Proxy statement | Apr 4, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 10-K · Annual report | Feb 25, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2025 | Results | SEC |
| 4 · Change in ownership | Jan 8, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 6, 2025 | Current report | SEC |
| 8-K · Current report | Dec 17, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Dec 4, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 3, 2024 | Other filings | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Nov 12, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Nov 4, 2024 | Offer document | SEC |
| 4 · Change in ownership | Nov 4, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 4, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2024 | Results | SEC |
| 8-K · Current report | Nov 4, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Sep 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Aug 12, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jul 29, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Jul 8, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2024 | Insider trade | SEC |
| 8-K · Current report | May 16, 2024 | Current report | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 8-K · Current report | May 13, 2024 | Management or board change | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 6, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 4, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 4, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Mar 25, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 8, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 6, 2024 | Other filings | SEC |
| 10-K · Annual report | Feb 28, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 28, 2024 | Management or board change | SEC |
| 8-K · Current report | Feb 28, 2024 | Results | SEC |
| 8-K/A · Current report, amended | Feb 27, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 25, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 20, 2023 | Material contract | SEC |
| 4 · Change in ownership | Dec 13, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 13, 2023 | Management or board change | SEC |
| 8-K · Current report | Dec 13, 2023 | Material contract | SEC |
| 4 · Change in ownership | Nov 3, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 25, 2023 | Quarterly report | SEC |
| 8-K · Current report | Oct 25, 2023 | Results | SEC |
| 4/A · Change in ownership, amended | Oct 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 5, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 15, 2023 | Current report | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 9, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 27, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jul 26, 2023 | Results | SEC |
| 4 · Change in ownership | Jul 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 6, 2023 | Insider trade | SEC |
| 8-K · Current report | Jun 21, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jun 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| SD · Specialized disclosure | May 31, 2023 | ESG report | SEC |
| 8-K · Current report | May 23, 2023 | Current report | SEC |
| 8-K · Current report | May 16, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Integra LifeSciences Holdings Corporation’s releases · as of Oct 22, 2026
- Common shares
- 77,800,976
- Fully diluted
- 77,800,976
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 77,800,976 | Oct 22, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 22, 2026 | 77,800,976 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anne VanLent Other companies: Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Novelion Therapeutics Inc (Director · Nov 29, 2016 – Dec 22, 2016 · Past); Traws Pharma, Inc. (Director · Jul 24, 2013 – Jun 15, 2015 · Past); Vaxart, Inc. (Director · May 1, 2013 – Jun 12, 2019 · Past); Aegerion Pharmaceuticals Inc (Director · Apr 26, 2013 – Nov 29, 2016 · Past); Ocera Therapeutics Inc (Director · Apr 1, 2011 – Dec 11, 2017 · Past); Barrier Therapeutics Inc (Exec VP & CFO · Mar 31, 2006 – Mar 14, 2008 · Past); Penwest Pharmaceuticals Co (Director · Jan 3, 2006 – Nov 4, 2010 · Past) | Director · May 17, 2006 – May 17, 2012 · Past |
| John B Henneman III Other companies: Orthofix Medical Inc. (Director · Since at least Jan 5, 2023); Anika Therapeutics Inc. (Director · Since at least Sep 3, 2020); Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019); R1 RCM Inc (Director · Apr 3, 2017 – Nov 19, 2024 · Past); Accretive Health Inc (Director · Feb 16, 2016 – Jan 3, 2017 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past); Lumos Pharma Inc (Chief Administrative Officer · Oct 1, 2014 – Oct 1, 2018 · Past) | CorpVP, CAO · Jan 6, 2006 – Aug 25, 2014 · Past |
| Thomas J Baltimore Jr Other companies: Comcast Corporation (Director · Since at least Mar 15, 2023); American Express Company (Director · Since at least Jan 27, 2021); Park Hotels & Resorts Inc. (CEO, Director · Since at least Dec 2, 2016); AutoNation, Inc. (Director · Apr 18, 2019 – Jan 4, 2021 · Past); RLJ Lodging Trust (President and CEO, Director · May 10, 2011 – May 11, 2016 · Past); Duke Realty Corporation (Director · Jan 28, 2009 – Apr 1, 2017 · Past); Prudential Financial, Inc. (Director · Oct 1, 2008 – Mar 15, 2023 · Past) | Director · Mar 5, 2007 – May 17, 2012 · Past |
| Jeffrey A. Graves Other companies: 3D Systems Corporation (President and CEO · Since at least May 26, 2020); FARO Technologies Inc (Director · Dec 11, 2017 – Jun 1, 2020 · Past); MTS Systems Corporation (President and CEO, Director · May 7, 2012 – Apr 17, 2020 · Past); Hexcel Corporation (Director · Jul 12, 2007 – Oct 6, 2023 · Past); Teleflex Incorporated (Director · May 4, 2007 – May 9, 2017 · Past); C&D Technologies Inc (President & CEO, Director · Dec 23, 2005 – May 3, 2010 · Past) | Director · Since at least Dec 12, 2023 |
| Neal Moszkowski Other companies: J.Jill, Inc. (Director · Jun 14, 2024 – Aug 20, 2024 · Past); R1 RCM Inc (Director · Apr 3, 2017 – Nov 19, 2024 · Past); Accretive Health Inc (Director · Feb 16, 2016 – Oct 1, 2016 · Past); JetBlue Airways Corporation (Director · May 18, 2006 – Dec 2, 2008 · Past); WellCare Health Plans Inc (Director · Mar 13, 2006 – Jul 30, 2009 · Past); Bluefly Inc (Director · Feb 17, 2006 – Feb 2, 2010 · Past) | Director · Aug 1, 2006 – May 22, 2013 · Past |
| Stuart M. Essig Other companies: Piper Sandler Companies (Director · Since at least Feb 4, 2026); IDEXX Laboratories, Inc. (Director · Since at least Jul 12, 2017); Orthofix Medical Inc. (Director · Jan 5, 2023 – Jan 5, 2023 · Past); Accendra Health, Inc. (Director · May 6, 2016 – Jun 28, 2019 · Past); St. Jude Medical Inc (Director · Apr 22, 2016 – Jan 4, 2017 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past) | president and chief executive officer, Chairman · Since at least Apr 4, 2016 |
| Christian S. Schade Other companies: Omega Therapeutics Inc (Director · Jul 10, 2023 – Jun 20, 2024 · Past); Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jul 28, 2022 · Past); Omthera Pharmaceuticals Inc (Executive VP and CFO · Apr 11, 2013 – Jul 16, 2013 · Past); NRG Energy, Inc. (Exec VP & Chief Financial Ofc · Mar 29, 2010 – Mar 29, 2011 · Past) | Director · Since at least May 17, 2006 |
| Donald E Morel Jr Other companies: Stevanato Group S.p.A. (Director · Since at least Mar 18, 2026); Catalent Inc (Director · Nov 13, 2015 – Dec 18, 2024 · Past); Kensey Nash Corp (Director · Mar 19, 2010 – Jun 22, 2012 · Past); West Pharmaceutical Services, Inc. (Chair of the Board & CEO · Dec 30, 2005 – Jun 30, 2015 · Past) | Director · Aug 27, 2013 – May 13, 2022 · Past |
| Mojdeh Poul Other companies: Align Technology, Inc. (Director · Since at least Dec 5, 2023); iRhythm Holdings, Inc. (Director · Jun 1, 2023 – May 29, 2024 · Past); Stanley Black & Decker, Inc. (Director · Feb 18, 2021 – Mar 18, 2025 · Past); 3M Company (Group President · Jul 1, 2018 – May 17, 2022 · Past) | President & CEO, Director · Since at least Jan 6, 2025 |
| Peter J. Arduini Other companies: GE HealthCare Technologies Inc. (President and CEO, GE HealthCare · Since at least Dec 14, 2022); Bristol-Myers Squibb Company (Director · Since at least Apr 1, 2016); GE Aerospace (Senior Vice President · Jan 1, 2022 – Mar 1, 2022 · Past); SeaSpine Holdings Corp (President, Director · Jun 11, 2015 – Jun 11, 2015 · Past) | President & CEO, Director · May 22, 2013 – Sep 2, 2021 · Past |
All 57 people
| Person | Seat |
|---|---|
| Barbara B. Hill Other companies: Omega Healthcare Investors, Inc. (Director · Since at least Apr 1, 2013); Accendra Health, Inc. (Director · Feb 9, 2017 – Jun 28, 2019 · Past); St. Jude Medical Inc (Director · Dec 6, 2007 – Jan 4, 2017 · Past) | Director · Since at least May 22, 2013 |
| Carrie L. Anderson Other companies: The Campbell's Company (Executive Vice President & CFO · Since at least Feb 6, 2023); Embecta Corp. (Director · Since at least Apr 1, 2022); Dover Corporation (Vice President and Controller · May 5, 2017 – Mar 15, 2019 · Past) | Executive Vice President & CFO · Jun 24, 2019 – Jul 1, 2022 · Past |
| Lloyd Howell Jr Other companies: GE HealthCare Technologies Inc. (Director · Since at least Jan 3, 2023); Moody's Corporation (Director · Since at least Mar 15, 2021); Booz Allen Hamilton Holding Corporation (EVP & Chief Financial Officer · Jan 9, 2018 – Sep 9, 2022 · Past) | Director · May 17, 2018 – May 13, 2020 · Past |
| Michael Damon Hutchinson Other companies: LivaNova PLC (SVP, CLO and Company Secretary · Since at least Nov 25, 2022); Varian Medical Systems Inc (SVP,Chief Legal Officer, Secy · Jun 1, 2020 – Apr 15, 2021 · Past); Stryker Corporation (VP, Chief Legal Officer · Apr 22, 2014 – Mar 21, 2019 · Past) | EVP, Chief Legal Officer & Sec · Since at least Jan 27, 2026 |
| Dan Reuvers Other companies: Neuronetics, Inc. (President & CEO · Since at least Mar 17, 2026); Tactile Systems Technology, Inc. (Director · Jun 8, 2020 – Mar 11, 2025 · Past) | CVP,PRES - CODMAN SPC SURGICAL · Dec 1, 2012 – May 11, 2020 · Past |
| Glenn Coleman Other companies: Charles River Laboratories International, Inc. (Chief Financial Officer · Since at least Feb 18, 2026); Dentsply Sirona Inc. (Executive VP & CFO · Sep 26, 2022 – Oct 11, 2024 · Past) | Executive Vice President & COO · Nov 16, 2015 – Jul 1, 2022 · Past |
| Mark A Augusti Other companies: ConforMIS Inc (FORMER PRESIDENT & CEO, Director · Nov 14, 2016 – Sep 5, 2023 · Past); Hutchinson Technology Inc (Director · Aug 16, 2010 – Feb 15, 2012 · Past) | CVP,PRES-ORTHO & TISSUE TECH · Apr 7, 2014 – Oct 7, 2016 · Past |
| Rhonda Germany Ballintyn Other companies: Univar Inc (Director · Aug 1, 2017 – Aug 8, 2019 · Past); Aegion Corporation (Director · Jan 4, 2017 – May 17, 2021 · Past) | Director · Jan 9, 2019 – May 14, 2021 · Past |
| Eric Schwartz Other companies: Globus Medical, Inc. (Senior VP and General Counsel · Mar 1, 2017 – Jun 25, 2018 · Past) | EVP, Chief Legal Officer & Sec · Nov 12, 2018 – Mar 11, 2025 · Past |
| James M Sullivan Other companies: SeaSpine Holdings Corp (Director · May 30, 2018 – May 30, 2018 · Past) | Director · Mar 6, 2018 – May 17, 2018 · Past |
| Jan De Witte Other companies: ResMed Inc. (Director · Since at least May 16, 2019) | President & CEO, Director · Dec 1, 2021 – Nov 1, 2024 · Past |
| Keith Bradley Other companies: SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past) | Director · Since at least Feb 23, 2006 |
| Lisa Evoli Other companies: Catalent Inc (SVP, Chief HR Officer · Aug 23, 2023 – Dec 18, 2024 · Past) | EVP & CHRO · Jan 13, 2016 – Mar 10, 2023 · Past |
| Andrea Caruso | Corporate Vice President and Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Brian Larkin | Corp VP, Pres.Gbl Spine &Ortho · Dec 1, 2012 – Apr 2, 2015 · Past |
| Chantal Veillon-Berteloot | EVP & CHRO · Since at least Aug 23, 2023 |
| Christopher Kilburn-Peterson | Corporate Vice President and President, Tissue Reconstruction · Since at least Jun 23, 2026 |
| Chris Ward | Investor Relations · Since at least Oct 30, 2026 |
| Deborah A Leonetti | Corp VP, Glbl Servs & Repair · Jan 3, 2006 – May 8, 2015 · Past |
| Dimitri Kvares | Corporate Vice President and Chief Information Officer · Since at least Nov 5, 2026 |
| Gerard S Carlozzi | Executive Vice President & COO · Jan 24, 2006 – Apr 1, 2010 · Past |
| Harvinder Singh | Executive Vice President and President, Specialty Surgery · Since at least Oct 3, 2022 |
| Jeff Graves | President, 3D Systems Corporation · Since at least Nov 4, 2026 |
| Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer · Since at least Oct 17, 2017 |
| Jerry E Corbin | Corp VP & Corporate Controller · Apr 2, 2007 – Jul 1, 2014 · Past |
| John Mooradian | Corp VP, Global Ops & Supp Chn · Dec 1, 2012 – Feb 13, 2020 · Past |
| Joseph Vinhais | Corp VP,Quality&Transformation · May 9, 2016 – Sep 11, 2019 · Past |
| Judith Ogrady | CorpVP,Global Reg.Affairs · Apr 1, 2013 – Feb 13, 2020 · Past |
| Kenneth Burhop | CORPVP,CHIEFSCIENTIFIC OFFICER · Mar 1, 2014 – Feb 13, 2020 · Past |
| Kerri DiPietro | Corporate Vice President and Chief Quality Officer · Since at least Feb 17, 2026 |
| Lea Daniels Knight | Executive Vice President and Chief Financial Officer · Since at least Jun 28, 2023 |
| Lesha Shinn | Corporate Vice President, Chief Legal Officer and Company Secretary · Since at least Sep 17, 2026 |
| Michael McBreen | Executive Vice President and Chief Commercial Officer · Since at least Jun 8, 2020 |
| Padma Thiruvengadam | Corp VP, Chief HR Officer · Dec 1, 2012 – Apr 2, 2015 · Past |
| Raymond G Murphy | Director · May 24, 2016 – May 9, 2024 · Past |
| Raymond Turner | Corporate Vice President and Chief Medical Officer · Since at least Apr 7, 2026 |
| Renee Lo | Director · Since at least Jul 18, 2022 |
| Richard D Gorelick | Corp VP, Gen Counsel & Sec · Dec 1, 2012 – Mar 23, 2018 · Past |
| Richard E Caruso | Director · Apr 27, 2006 – May 24, 2016 · Past |
| Rick Maveus | Senior Vice President, Transformation and Program Management Office · Since at least May 5, 2025 |
| Robert D Paltridge | Corp VP, Pres. Adv Woundcare · Dec 1, 2012 – Jul 1, 2014 · Past |
| Robert T. Davis | Executive Vice President and President, Tissue Reconstruction and Distributed Technologies · Since at least Jun 23, 2026 |
| Robert T Davis Jr | EVP & President, TR&DT · Since at least Jul 24, 2019 |
| Shaundra Clay | Director · Since at least Apr 1, 2021 |
| Teshtar Elavia | Corporate Vice President and Chief Technology Officer · Since at least Feb 17, 2026 |
| Topaz Joy Kirlew | Corporate Vice President and Chief Regulatory Officer · Since at least Jul 2, 2026 |
| Valerie Young | Corporate Vice President, Global Supply Chain · Since at least May 5, 2025 |
Log in to ask 6ix AI your own questions about Integra LifeSciences Holdings Corporation.